Observational studyScientific reports2025
Early detection of retinal dysfunction in type 1 diabetes without retinopathy using multifocal electroretinography.
Observational study in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Visual Pathways Involvement in Friedreich's Ataxia Patients Without Macular Impairment.Journal of clinical medicine · 2026Article
- Retinal Outcomes in Diabetes: Antihyperglycemic Therapy, EWDR, and Perioperative Considerations.Biomedicines · 2026Review
- Exerkines in diabetic retinopathy: from mechanisms to therapeutic prospects.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Diabetic retinopathy (DR) significantly impacts vision and quality of life in diabetic patients. This study aimed to evaluate multifocal electroretinogram (mfERG) changes in long-term type 1 diabetes mellitus (T1DM) patients without clinical signs of DR to detect early functional retinal alterations. A prospective observational study was conducted involving 46 eyes from 23 T1DM patients and 46 eyes from 23 age-matched healthy controls. mfERG was assessed using the RETI-port/scan21 following ISCEV protocols. T1DM patients exhibited significantly decreased mfERG response amplitude density (RAD) in all the retinal rings except R2 (R1, p = 0.003; R3, p = 0.006, R4, p = 0.023 and R5, p = 0,027) and in the inferior quadrants Q2 and Q3 (p = 0.030 and p = 0.004, respectively) compared to controls. Minimal differences in implicit time (IT) were observed between both groups. Age correlated positively with different ITs, and HbA1c showed a significant negative correlation with various RADs. T1DM patients show early retinal dysfunction, as indicated by reduced RAD in mfERG, even without clinical signs of DR. These findings highlight the importance of early functional testing and metabolic control in preventing DR progression. RAD may serve as a subclinical marker of bipolar cell and photoreceptor damage in long-term T1DM patients prior to the onset of clinical DR.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.